YOLFTbeta
DIAMOND BIOFUND INC

DIAMOND BIOFUND INC

6901 · TW · Financial Services / Asset Management

14.30TWD+0.55 (+4.00%)

Price History

Full chart

Market Stats

Previous Close13.75
Open13.85
Day Range13.85 – 14.45
52-Week Range12.05 – 22.40
Volume1.83M
Market Cap14.50B
P/E (TTM)4.96
Forward P/E0.00
EPS3.43
Dividend Yield0.00%
Beta0.95
50-Day Avg16.20
200-Day Avg15.93

About

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Company Details

Leadership

  • Mr. Kung-Ming LuGeneral Manager
  • Ms. You-Mei WuChairman's Office Supervisor · b. 1964
  • Ms. Chin-Ling LuAssistant Vice President
  • Ms. Yuehlin KuoFinancial Officer
  • Junru JianAccounting supervisor

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-------596.00K
Cost of Revenue------27.98M
Gross Profit-------28.58M
Gross Margin------4794.63%
Operating Expense------1.25B
Operating Income-367.78M6.10B-102.43M-137.59M-162.23M-180.85M-1.28B
Operating Margin------214524.66%
EBITDA-53.90M6.13B2.97B892.83M-2.57B-2.36B-1.14B
EBITDA Margin------191735.91%
Net Income-370.87M6.09B2.85B797.78M-2.58B-2.52B-1.17B
Net Income Margin------197102.68%
Interest Expense-663.00K552.00K245.00K806.00K3.77M3.09M
Interest Expense % of Total Revenue-------518.12%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.08B9.28B10.62B11.19B13.04B10.67B9.36B
Total Liabilities68.67M180.16M230.82M144.06M179.74M301.55M137.79M
Total Equity3.01B9.10B10.39B11.05B12.86B10.37B9.22B
Cash416.14M220.52M18.14M333.84M2.10B126.23M2.76B
Total Debt61.47M50.61M41.99M3.67M129.01M117.83M93.93M
Net Debt-354.67M-169.91M23.86M-330.17M-1.97B-8.40M-2.66B

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-39.57M-72.99M-300.42M473.09M-195.82M1.14B-165.92M
Investing Cash Flow59.76M-114.84M114.84M2.48M-2.40B-3.12B2.80B
Financing Cash Flow-9.10M-9.32M-16.80M-159.87M4.36B1.02M-8.06M
Capital Expenditure1.48M002.05M19.48M14.24M189.00K
Free Cash Flow-41.05M-72.99M-300.42M471.04M-214.93M1.12B-166.11M
Dividends Paid---150.00M127.00M--
FCF to OCF103.75%100.00%100.00%99.57%109.76%98.70%100.11%
Dividend Paid to FCF---31.84%-59.09%--

Key Statistics & Ratios

Market Cap14.50B
Enterprise Value6.30B
Trailing P/E4.96
Forward P/E0.00
Price / Sales4.79
Price / Book1.09
EPS3.43
Book Value14.43
Revenue (TTM)3.02B
Gross Profit (TTM)3.02B
EBITDA2.88B
Profit Margin96.70%
Operating Margin98.80%
Return on Equity26.97%
Return on Assets16.38%
Shares Outstanding852.86M
Shares Float176.31M
Beta0.95
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.20Aug 7, 2023
20221×
0.25Nov 23, 2022

Stock Splits

  • Aug 7, 20231180:1000
  • Nov 23, 20221270:1000